SCHEMBL7403531

SCHEMBL7403531

[CH]=CCCCCC1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.50
▸ CYP1A2 P05177 1/20 0.48
▸ EPHX1 P07099 1/20 0.36
▸ GPR84 Q9NQS5 1/20 0.35
▸ KDM5A P29375 2/20 0.34
▸ PHF8 Q9UPP1 2/20 0.34
▸ KDM2A Q9Y2K7 2/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ CHRM5 P08912 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CEL P19835 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL452274 1.00 SIGMAR1 (0.50) SIGMAR1CYP1A2EPHX1GPR84KDM5A
SCHEMBL6589344 0.93 CYP1A2 (0.50) SIGMAR1CYP1A2EPHX1GPR84KDM5A
SCHEMBL450392 0.93 CYP1A2 (0.50) SIGMAR1CYP1A2EPHX1GPR84KDM5A
SCHEMBL6033221 0.91 CYP1A2 (0.46) SIGMAR1CYP1A2EPHX1GPR84KDM5A
SCHEMBL542157 0.88 — —
SCHEMBL6593465 0.86 SIGMAR1 (0.38) SIGMAR1CYP1A2KDM5APHF8KDM2A
SCHEMBL6593058 0.86 — —
SCHEMBL441909 0.83 CYP1A2 (0.42) SIGMAR1CYP1A2EPHX1CHRM5ADRA2C
SCHEMBL8837639 0.81 SIGMAR1 (0.54) SIGMAR1CYP1A2EPHX1GPR84KDM5A
SCHEMBL542400 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891331-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY Vertex Pharmaceuticals Incorporated (US) 1999-01-20 — — EP disclosed
WO-1997036869-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-10-09 — — WO disclosed
Send feedback